My reaction is more mixed than Romeo’s, but I see enough promise that I’m leaning toward buying their $100k full preservation pre-sale.
I’m moderately confident that their technology is better than Alcor’s. I haven’t investigated it as carefully as Romeo has. I’ve paid enough attention to this field that I think I would have heard of significant problems if people saw them, and there seem to be no criticisms of its suitability for uploading.
Aurelia seems smart. I have some concerns about her business skills.
She tried to get me to invest in Nectome in June. I declined, evaluating it primarily on Nectome’s financial prospects. Her revenue forecasts seemed wildly optimistic, disagreeing with my impressions much more than is normal for a startup.
But this winter I’ve been shifting to thinking of doing something to support Nectome financially, in order to increase the chance that they’ll be available if I need them. This shift is largely a result of increased wealth from AI-related investments, not any new information about Nectome.
Aurelia, could you estimate the minimum revenues required for Nectome to maintain its ability to perform preservations?
Note that the 2015 paper that Aurelia mentioned was one that she co-authored with Greg Fahy. Fahy is highly respected among cryonicists for, among other things, his role in persuading the cryobiology community to tolerate cryonics. Fahy has also pioneered a treatment that seems to partially reverse aging (that company needs and deserves more investment).
Note that Aurelia also works at Michael Andregg’s Eon Systems, which has recently uploaded a fruit fly.
Now that I see this tweet from Ken Hayworth, it looks like you’re probably right about the fly upload.